Meltzer S J, Ahnen D J, Battifora H, Yokota J, Cline M J
Gastroenterology. 1987 May;92(5 Pt 1):1174-80. doi: 10.1016/s0016-5085(87)91074-2.
To determine the frequency and clinical significance of oncogene abnormalities in colon cancer, deoxyribonucleic acids from 45 colon carcinomas and 15 benign adenomas were hybridized with 14 different protooncogene probes. Abnormalities of oncogenes were found in 22% of cancers at the time of resection. Amplification of c-myc or c-erbB-2 and allelic deletion of c-ras-Ha or c-myb were the most frequent abnormalities. The presence of altered oncogenes did not correlate with Dukes' stage, tumor progression, or patient survival after resection. One adenoma had an allelic deletion of the c-myb oncogene which was not seen in either the normal colon or an adjacent carcinoma. These data indicate that the spectrum of altered protooncogenes in colon carcinoma is similar to that of other adenocarcinomas, and that unstable oncogenes can be found before overt malignancy develops.
为确定结肠癌中癌基因异常的频率及其临床意义,我们将45例结肠癌和15例良性腺瘤的脱氧核糖核酸与14种不同的原癌基因探针进行杂交。在切除时,22%的癌症中发现了癌基因异常。c-myc或c-erbB-2的扩增以及c-ras-Ha或c-myb的等位基因缺失是最常见的异常情况。癌基因改变的存在与Dukes分期、肿瘤进展或切除术后患者生存率无关。有1例腺瘤存在c-myb癌基因的等位基因缺失,在正常结肠或相邻癌中均未见到这种情况。这些数据表明,结肠癌中原癌基因改变的谱与其他腺癌相似,并且在明显的恶性肿瘤发生之前就能发现不稳定的癌基因。